Keywords: arrow, therapeutics, raises, l11, million, venture, capital
Arrow Therapeutics raises L11.1 million in venture capital financing
Article | 11 July 2000
Arrow Therapeutics, a UK-based specialist in anti-infectives, has raisedL11.1 million ($16.8 million) in a venture capital round, which it claims is ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
